These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20007782)

  • 41. Toxin acidic residue evolutionary function-guided design of de novo peptide drugs for the immunotherapeutic target, the Kv1.3 channel.
    Chen Z; Hu Y; Hong J; Hu J; Yang W; Xiang F; Yang F; Xie Z; Cao Z; Li W; Lin D; Wu Y
    Sci Rep; 2015 May; 5():9881. PubMed ID: 25955787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Isolation, chemical and functional characterization of several new K(+)-channel blocking peptides from the venom of the scorpion Centruroides tecomanus.
    Olamendi-Portugal T; Bartok A; Zamudio-Zuñiga F; Balajthy A; Becerril B; Panyi G; Possani LD
    Toxicon; 2016 Jun; 115():1-12. PubMed ID: 26921461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ImKTx88, a novel selective Kv1.3 channel blocker derived from the scorpion Isometrus maculates.
    Han S; Hu Y; Zhang R; Yi H; Wei J; Wu Y; Cao Z; Li W; He X
    Toxicon; 2011 Feb; 57(2):348-55. PubMed ID: 21194541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1.3 channels of human T cells with improved selectivity.
    Csoti A; Del Carmen Nájera Meza R; Bogár F; Tajti G; Szanto TG; Varga Z; Gurrola GB; Tóth GK; Possani LD; Panyi G
    Biochem Pharmacol; 2022 May; 199():115023. PubMed ID: 35358481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of a new Kv1.3 channel-specific blocker, J123, from the scorpion Buthus martensii Karsch.
    Shijin Y; Hong Y; Yibao M; Zongyun C; Han S; Yingliang W; Zhijian C; Wenxin L
    Peptides; 2008 Sep; 29(9):1514-20. PubMed ID: 18571286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hg1, novel peptide inhibitor specific for Kv1.3 channels from first scorpion Kunitz-type potassium channel toxin family.
    Chen ZY; Hu YT; Yang WS; He YW; Feng J; Wang B; Zhao RM; Ding JP; Cao ZJ; Li WX; Wu YL
    J Biol Chem; 2012 Apr; 287(17):13813-21. PubMed ID: 22354971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms Underlying the Inhibition of KV1.3 Channel by Scorpion Toxin ImKTX58.
    Zhang X; Zhao Q; Yang F; Lan Z; Li Y; Xiao M; Yu H; Li Z; Zhou Y; Wu Y; Cao Z; Yin S
    Mol Pharmacol; 2022 Sep; 102(3):150-160. PubMed ID: 35764383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tethered peptide neurotoxins display two blocking mechanisms in the K
    Zhao R; Dai H; Mendelman N; Chill JH; Goldstein SAN
    Sci Adv; 2020 Mar; 6(10):eaaz3439. PubMed ID: 32181366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. KcsA-Kv1.x chimeras with complete ligand-binding sites provide improved predictivity for screening selective Kv1.x blockers.
    Szekér P; Bodó T; Klima K; Csóti Á; Hanh NN; Murányi J; Hajdara A; Szántó TG; Panyi G; Megyeri M; Péterfi Z; Farkas S; Gyöngyösi N; Hornyák P
    J Biol Chem; 2024 Apr; 300(4):107155. PubMed ID: 38479597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of a toxin from the scorpion Tityus serrulatus with a cloned K+ channel from squid (sqKv1A).
    Ellis KC; Tenenholz TC; Jerng H; Hayhurst M; Dudlak CS; Gilly WF; Blaustein MP; Weber DJ
    Biochemistry; 2001 May; 40(20):5942-53. PubMed ID: 11352729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ImKTx96, a peptide blocker of the Kv1.2 ion channel from the venom of the scorpion Isometrus maculates.
    Li S; Sunchen S; He D; Qin C; Zuo Z; Shen B; Cao Z; Hong W; Miao L
    Peptides; 2020 Jan; 123():170172. PubMed ID: 31626826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chinese-scorpion (Buthus martensi Karsch) toxin BmK alphaIV, a novel modulator of sodium channels: from genomic organization to functional analysis.
    Chai ZF; Zhu MM; Bai ZT; Liu T; Tan M; Pang XY; Ji YH
    Biochem J; 2006 Nov; 399(3):445-53. PubMed ID: 16800812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic peptides as tools to investigate the structure and pharmacology of potassium channel-acting short-chain scorpion toxins.
    Lecomte C; Sabatier JM; Van Rietschoten J; Rochat H
    Biochimie; 1998 Feb; 80(2):151-4. PubMed ID: 9587672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A subfamily of acidic alpha-K(+) toxins.
    Huys I; Olamendi-Portugal T; Garcia-Gómez BI; Vandenberghe I; Van Beeumen J; Dyason K; Clynen E; Zhu S; van der Walt J; Possani LD; Tytgat J
    J Biol Chem; 2004 Jan; 279(4):2781-9. PubMed ID: 14561751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
    Mourre C; Chernova MN; Martin-Eauclaire MF; Bessone R; Jacquet G; Gola M; Alper SL; Crest M
    J Pharmacol Exp Ther; 1999 Dec; 291(3):943-52. PubMed ID: 10565809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and characterization of a novel scorpine-like peptide Ev37, from the scorpion Euscorpiops validus.
    Feng J; Yu C; Wang M; Li Z; Wu Y; Cao Z; Li W; He X; Han S
    Protein Expr Purif; 2013 Mar; 88(1):127-33. PubMed ID: 23262394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toxin-induced conformational changes in a potassium channel revealed by solid-state NMR.
    Lange A; Giller K; Hornig S; Martin-Eauclaire MF; Pongs O; Becker S; Baldus M
    Nature; 2006 Apr; 440(7086):959-62. PubMed ID: 16612389
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases.
    Rashid MH; Huq R; Tanner MR; Chhabra S; Khoo KK; Estrada R; Dhawan V; Chauhan S; Pennington MW; Beeton C; Kuyucak S; Norton RS
    Sci Rep; 2014 Mar; 4():4509. PubMed ID: 24676092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells.
    Varga Z; Gurrola-Briones G; Papp F; Rodríguez de la Vega RC; Pedraza-Alva G; Tajhya RB; Gaspar R; Cardenas L; Rosenstein Y; Beeton C; Possani LD; Panyi G
    Mol Pharmacol; 2012 Sep; 82(3):372-82. PubMed ID: 22622363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of the first K⁺ channel blockers from the venom of the Moroccan scorpion Buthus occitanus Paris.
    Martin-Eauclaire MF; Céard B; Belghazi M; Lebrun R; Bougis PE
    Toxicon; 2013 Dec; 75():168-76. PubMed ID: 23523531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.